OmniAb Inc. (NASDAQ: OABI)
$4.75
+0.1400 ( +3.04% ) 574.9K
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Market Data
Open
$4.75
Previous close
$4.61
Volume
574.9K
Market cap
$557.50M
Day range
$4.61 - $4.75
52 week range
$3.56 - $6.72
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Nov 14, 2023 |
4 | Insider transactions | 1 | Nov 13, 2023 |
8-k | 8K-related | 15 | Nov 09, 2023 |
10-q | Quarterly Reports | 76 | Nov 09, 2023 |
4 | Insider transactions | 2 | Nov 02, 2023 |
3 | Insider transactions | 1 | Nov 01, 2023 |
4 | Insider transactions | 1 | Nov 01, 2023 |
8-k | 8K-related | 13 | Nov 01, 2023 |
4 | Insider transactions | 1 | Aug 15, 2023 |
10-q | Quarterly Reports | 77 | Aug 10, 2023 |